Creative Planning’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$543K Buy
58,916
+8,513
+17% +$78.5K ﹤0.01% 2392
2025
Q1
$432K Buy
50,403
+6,453
+15% +$55.4K ﹤0.01% 2417
2024
Q4
$472K Buy
43,950
+4,079
+10% +$43.8K ﹤0.01% 2270
2024
Q3
$226K Buy
39,871
+14,010
+54% +$79.6K ﹤0.01% 2742
2024
Q2
$109K Buy
25,861
+1,730
+7% +$7.3K ﹤0.01% 2811
2024
Q1
$123K Buy
24,131
+5,576
+30% +$28.4K ﹤0.01% 2656
2023
Q4
$173K Buy
18,555
+6,778
+58% +$63.1K ﹤0.01% 2465
2023
Q3
$77.1K Sell
11,777
-1,159
-9% -$7.59K ﹤0.01% 2413
2023
Q2
$105K Sell
12,936
-178
-1% -$1.45K ﹤0.01% 2325
2023
Q1
$112K Sell
13,114
-688
-5% -$5.9K ﹤0.01% 2228
2022
Q4
$128K Sell
13,802
-6,113
-31% -$56.6K ﹤0.01% 2105
2022
Q3
$206K Sell
19,915
-16,000
-45% -$166K ﹤0.01% 1884
2022
Q2
$360K Buy
35,915
+2,700
+8% +$27.1K ﹤0.01% 1484
2022
Q1
$409K Buy
33,215
+12,700
+62% +$156K ﹤0.01% 1437
2021
Q4
$356K Buy
+20,515
New +$356K ﹤0.01% 1508
2021
Q2
Sell
-17,750
Closed -$265K 2017
2021
Q1
$265K Buy
+17,750
New +$265K ﹤0.01% 1836
2017
Q3
Sell
-2,280
Closed -$12K 1988
2017
Q2
$12K Hold
2,280
﹤0.01% 3455
2017
Q1
$13K Sell
2,280
-200
-8% -$1.14K ﹤0.01% 3370
2016
Q4
$10K Buy
2,480
+200
+9% +$806 ﹤0.01% 3482
2016
Q3
$8K Sell
2,280
-9,500
-81% -$33.3K ﹤0.01% 3556
2016
Q2
$72K Hold
11,780
﹤0.01% 1867
2016
Q1
$58K Sell
11,780
-940
-7% -$4.63K ﹤0.01% 1975
2015
Q4
$71K Buy
+12,720
New +$71K ﹤0.01% 1820